|
[1]Friedman SL, Rockey DC, Bissell DM.Hepatic fibrosis 2006:Report of the AASLD single topic conference[J].Hepatolo-gy, 2007, 45 (1) :242-249.
|
|
[2]Mannign DS, Afdhal NH.Diagnosis and quantitation of fibro-sis[J].Gastroenterology, 2008, 134 (6) :1670-1681.
|
|
[3]Prakash S, Wyler DJ.Fibroblast stimulation in schistosomia-sis.X11:identification of CD4+lymphocytes within schisto-somal egg granulomas as a source of an apparently novel fi-broblast growth factor (FsF-1) [J].J Immunol, 1992, 148 (11) :3583-3587.
|
|
[4]Prakash S, Nanji AA, Robbins PW.Fibrosin:A novel lym-phokine in alcohol-induced fibrosis[J].Exp Mol Pathol, 1999;67 (1) :40-49.
|
|
[5]中华医学会.慢性乙型肝炎防治指南[J].传染病信息, 2005, (S1) :1-17.
|
|
[6]中华医学会.病毒性肝炎防治方案[J].中华肝脏病杂志, 2000, 8:627-634.
|
|
[7]Friedman SL.Hepatic stellate cell:protean, multifunctional, e-nigmatic cells of the liver[J].Physol Rev, 2008, 88:125-172.
|
|
[8]梁巧丽, 周最明, 唐银丽, 等.肝纤维化形成过程中肝星状细胞的活化机制[J].国外医学:生理病理与临床分册, 2001, 21 (1) :55.
|
|
[9]Prakash S, Robbins PW, Wyler DJ.Cloning and analysis ofmurine Cdna that encodes a fibrogenic limphokine, fibrosin[J], Proc Nat Acad Sci U S A, 1995, 92 (6) :2154-2158.
|
|
[10]Prakash S, Paul WE, Robbins PW.Fibrosin, a novel fibro-genic cytokine, modulates expression of myofibroblasts[J].Exp Mol Pathol, 2007, 82 (1) :42-48.
|
|
[11]欧晓娟, 王晓明, 贾继东, 等.慢性乙型肝炎肝穿病理与血清HBV-DNA及肝功能的关系[J].首都医科大学学报, 2006, 27 (4) :435-437.
|
|
[12]Chen J, Jiang JJ, Zheng Q.Mathematical modeds suingconventional laboratory indicators to predict hepatic firosinprogressing in chronic hepatitis B[J].Zhonghua Yi Xue ZaZhi, 2009, 89 (33) :2349-2352.
|
|
[13]柳龙根, 翟德芳, 刘建红, 等.乙肝肝炎患者血清HBV DNA负荷与其肝功能及肝组织损伤的关系研究[J].临床肝胆病杂志, 2005, 20 (1) :728.
|
|
[14]Anderson FH, ZengL, Rock NR, et al.An assessment of theclinical utility of serum ALT and AST in chronic hepatients C[J].Hepatol Res, 2000, 18 (1) :63-67.
|
|
[15]李嘉, 赵桂明, 朱理珉, 等.免疫耐受期和非活动复制期乙型肝炎病毒感染者的肝脏病理与临床特征[J].中华肝脏病杂志, 2007, 15 (5) :326-329.
|
|
[16]马丽娜, 何志敏, 曹振环, 等.乙型肝炎病毒携带者的肝脏病理学与临床特征[J].中华肝脏病杂志, 2010, 18 (6) :433-436.
|
DownLoad: